SU1697756A1 - Method for treating laryngeal diseases with persistent nonclosure of vocal folds - Google Patents

Method for treating laryngeal diseases with persistent nonclosure of vocal folds Download PDF

Info

Publication number
SU1697756A1
SU1697756A1 SU884445103A SU4445103A SU1697756A1 SU 1697756 A1 SU1697756 A1 SU 1697756A1 SU 884445103 A SU884445103 A SU 884445103A SU 4445103 A SU4445103 A SU 4445103A SU 1697756 A1 SU1697756 A1 SU 1697756A1
Authority
SU
USSR - Soviet Union
Prior art keywords
persistent
nonclosure
vocal folds
treating laryngeal
vocal
Prior art date
Application number
SU884445103A
Other languages
Russian (ru)
Inventor
Виталий Николаевич Горбачевский
Борис Иванович Павлык
Александр Кузьмич Покотиленко
Татьяна Ивановна Кучеренко
Надежда Владимировна Кокоша
Original Assignee
Киевский Научно-Исследовательский Институт Отоларингологии Им.Проф.А.Коломийченко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киевский Научно-Исследовательский Институт Отоларингологии Им.Проф.А.Коломийченко filed Critical Киевский Научно-Исследовательский Институт Отоларингологии Им.Проф.А.Коломийченко
Priority to SU884445103A priority Critical patent/SU1697756A1/en
Application granted granted Critical
Publication of SU1697756A1 publication Critical patent/SU1697756A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Изобретение относитс  к медицине, а именно к отоларингологии. Цель изобретени  - предупреждение рецидивов. В качестве полимера субмукозно в голосовую складку ввод т 3%-ный полиакри-амидный гель. Преимуществом способа  вл етс  отсутствие воспалительной реакции в области иньекции и отсутствие миграции введенного препарата, что позвол ет получить стойкий эффект.The invention relates to medicine, namely to otolaryngology. The purpose of the invention is to prevent recurrences. As a submucous polymer, a 3% polyacryamide gel is introduced into the vocal fold. The advantage of this method is the absence of an inflammatory reaction in the area of injection and the absence of migration of the administered preparation, which allows to obtain a lasting effect.

Description

(S(S

СWITH

Изобретение относитс  к медицине, а именно к отоларингологии.The invention relates to medicine, namely to otolaryngology.

Цель изобретени  - предупреждение рецидивов.The purpose of the invention is to prevent recurrences.

Способ выполн ют следующим образом .The method is performed as follows.

Субмукозно в голосовые св зки ввод т 3%-ный полиа риламидный гель до восполнени  недостающих объемов.A 3% polyamide gel was added to the vocal cords submucous before filling the missing volumes.

Пример. Б-на , Р-на О.А., 53 лет. Диагноз: паралич правой половины гортани . Субмукозно в среднюю треть правой голосовой складки введено 1,0 3%-ного ПА- АГ. Воспалительна  реакци  в послеоперационном периоде практически отсутствовала. Размер голосовой щели уменьшилс . По вилс  сиплый голос средней звучности.Example. Б-на, Р-на О.А., 53 years. Diagnosis: paralysis of the right half of the larynx. Submucous in the middle third of the right vocal fold was introduced 1.0 3% PA-AG. The inflammatory response in the postoperative period was practically absent. The size of the glottis has decreased. By willows hoarse voice of medium sonority.

Преимущество предлагаемого способа состоит в том, что отсутствие воспалительной реакции и миграции введенного препарата позвол ет получить стойкий функциональный эффект и предупредить рецидивы.The advantage of the proposed method is that the absence of an inflammatory reaction and the migration of the administered preparation allows to obtain a stable functional effect and prevent relapses.

Claims (1)

Формула изобретени Invention Formula Способ лечени  заболеваний гортани со стойким несмыканием голосовых складок путем инъекционного введени  в голосовую складку полимера до восполнени  ее объема , отличающийс  тем, что. с целью предупреждени  рецидивов, в качестве полимера в голосовую складку ввод т 3%-ный полиакриламидный гельA method of treating diseases of the larynx with persistent uncoupling of the vocal folds by injecting polymer into the vocal fold to fill up its volume, characterized in that. in order to prevent recurrence, 3% polyacrylamide gel is introduced into the vocal fold as a polymer ОABOUT ч:h: VJVj VJVj О1 аO1 a
SU884445103A 1988-06-20 1988-06-20 Method for treating laryngeal diseases with persistent nonclosure of vocal folds SU1697756A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU884445103A SU1697756A1 (en) 1988-06-20 1988-06-20 Method for treating laryngeal diseases with persistent nonclosure of vocal folds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU884445103A SU1697756A1 (en) 1988-06-20 1988-06-20 Method for treating laryngeal diseases with persistent nonclosure of vocal folds

Publications (1)

Publication Number Publication Date
SU1697756A1 true SU1697756A1 (en) 1991-12-15

Family

ID=21383218

Family Applications (1)

Application Number Title Priority Date Filing Date
SU884445103A SU1697756A1 (en) 1988-06-20 1988-06-20 Method for treating laryngeal diseases with persistent nonclosure of vocal folds

Country Status (1)

Country Link
SU (1) SU1697756A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742022A4 (en) * 1994-08-10 1996-11-25 Maloe Vnedrencheskoe Predpr In Biologically compatible hydrogel
US7186419B2 (en) 2000-08-25 2007-03-06 Contura Sa Polyacrylamide hydrogel for arthritis
US7678146B2 (en) 2000-08-25 2010-03-16 Contura A/S Polyacrylamide hydrogel and its use as an endoprosthesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Авторское свидетельство СССР № 1055485, кл. А 61 В 17/00, 1988. *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742022A4 (en) * 1994-08-10 1996-11-25 Maloe Vnedrencheskoe Predpr In Biologically compatible hydrogel
USRE38913E1 (en) 1994-08-10 2005-12-06 Contura Sa Biocompatible hydrogel
US7186419B2 (en) 2000-08-25 2007-03-06 Contura Sa Polyacrylamide hydrogel for arthritis
US7678146B2 (en) 2000-08-25 2010-03-16 Contura A/S Polyacrylamide hydrogel and its use as an endoprosthesis
US7780958B2 (en) 2000-08-25 2010-08-24 Contura Sa Polyacrylamide hydrogel for the treatment of incontinence and vesicouretal reflux
US7790194B2 (en) 2000-08-25 2010-09-07 Contura A/S Polyacrylamide hydrogel as a soft tissue filler endoprosthesis
US8216561B2 (en) 2000-08-25 2012-07-10 Contura A/S Polyacrylamide hydrogel for the treatment of incontinence and vesicouretal reflex

Similar Documents

Publication Publication Date Title
SU1748644A3 (en) Method for synthesis of azacycloalkane derivatives
RU2190594C2 (en) Organic nitrates and pharmaceutical composition showing activity inhibiting platelet aggregation based on thereof
Makino et al. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I.
KR850007559A (en) Implantable Formulations of Regulatory Peptides
KR900018129A (en) Sulphoamino derivatives of chondroitin sulfate, dermatan sulfate and hyaluronic acid and their pharmaceutical properties
FI814230L (en) THERAPEUTIC AND DIAGNOSTIC COMPOSITORS AND THERAPEUTIC COMPOSITION WITH BACTERIAL INFECTION
US4029793A (en) Synergistic local anesthetic compositions
SU1697756A1 (en) Method for treating laryngeal diseases with persistent nonclosure of vocal folds
ATE85809T1 (en) PRODUCTION OF HUMAN VON WILLEBRAND FACTOR BY RECOMBINANT DNA.
Jernelöv et al. Adaptation to an acid environment in Chironomus riparius (Diptera, Chironomidae) from Smoking Hills, NWT, Canada
GB1483837A (en) Polypeptide hormone
KR890000428A (en) Novel 2-pyrazoline derivatives and therapeutic agents for cerebrovascular diseases containing the same
KR890013178A (en) Human Colony Stimulator
JPS6237007B2 (en)
KR890012942A (en) 5-substituted ornithine derivatives
JPS5513742A (en) Aromatic polyamide film and its production
JPS6354386A (en) Phospholipid and use thereof
KR850005065A (en) Herbal form for oral administration of sulfide
Martin et al. Purification and characterization of eight toxins from the Brazilian scorpion Tityus serrulatus
JPS57106611A (en) Coating remedy
Golman et al. Metrizamide in Experimental Urography: I. Iodine Concentration and Flow of Urine following Intravenous Injection of an Ionic and a Non-Ionic Contrast Medium in Rabbits
KR910009723A (en) 4-carbamoyl-1-β-D-ribofuranosyl imidazolium-5-oleate anhydrous crystals
KR910000600A (en) Propanolamine derivatives
Wu CHARACTERISTICS OF BOVINE INTRAMUSCULAR COLLAGEN UNDER VARIOUS POSTMORTEM CONDITIONS.
GB1382427A (en) Composition and method for strengthening nails